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Renal handling of urea in subjects with persistent axotemia and normal 
renal function. Fourteen subjects with persistent azotemia and normal 
glomerular filtration rate were studied hy renal clearances and hormonal 
determinations to establish the nephron site of altered urea transport 
and the mechanism(s) responsible for their azotemia. During constant 
alimentary protein. urea nitrogen appearance was normal and urea 
clearance was much lower than in 10 age-matched control subjects 
(23,3:+: 2.1 mlhnin and49.6:+: 2.6 mllmin per 1.73 m2• P < 0.(01). Inulin 
and para-aminohippurate clearances. blood volume and plasma concen-
tration of antidiuretic hormone were within normal limits. During 
maximal antidiuresis, in spite of greater urea filtered load, the urinary 
excretion of urea was less. and hoth the maximum urinary osmolality 
and the free-water reabsorption relative to osmolar clearance per unit 
of GFR were greater than in control subjects. After sustained water 
diuresis. the plasma urea concentration markedly decreased to near 
normal levels in azotemic suhjects, The basal urinary excretion of 
prostaglandins E2 was significantly reduced in azotcmic subjects and 
was directly correlated with fractional urea clearance (I' = 0.857. P < 
0.(01). An additional of control subjects (lY = 8) showed a 
marked reduction of clearance of urea after inhibition of 
prostaglandin synthesis (P < 0,0]). These data suggest that azotemia is 
due to incrca)sed tubular reabsorption of urea in the distal part of 
nephron. presumably hecause of increased back diffusion in the papil-
lary collecting duct. accounting for the enhanced maximum urinary 
osmolality and free-water reabsorption. Renal prostaglandin E2 may 
partecipate in the pathogenesis of azotemia by altering recycling of urea 
in the medulla, 
Plasma urea level is measured as an index of renal 
function but is generally recognized that it may be raised for 
reasons other than impairment of renal function [I, 2]. In spite 
of normal glomerular filtration rate (GFR). in fact, azotemia 
may be due either to extrarenal factors (such as excessive 
protein intake. increased catabolism or abnormal urea 
metabolism) [3. 4] or to renal causes. Azotemia of renal origin 
has been attributed to an increase of net urea reabsorption. such 
as during salt depletion [5]. during diuretic therapy [6] and, in 
single subjects, because of a genetic defect in renal handling of 
urea (familial azotemia) 17 . In the last study [7], renal clearance 
studies were performed in two subjects and did not allow 
an establishment of the tubular site nor the intrarenal mecha-
nism responsible for the urea retention, 
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In the present investigation, renal clearances and urea nitro-
gen appearance in 14 subjects with azotemia, as 
compared with 10 age-matched control indicated that 
an increase in net tubular reabsorption of urea was responsible 
for the elevated plasma urea concentration in all subjects, 
despite a normal renal function, The aim of this study was, 
therefore, to indicate the nephron site of altered urea transport 
and the intrarenal mechanism(s) responsible for the decrease in 
urea excretion, using renal clearances antidiuresis and 
water diuresis, and determination of concentration of 
antidiuretic hormone (AD H) and urinary excretion of renal 
prostaglandin (PGs)' It has been recently shown in animals, in 
fact, that renal PG s may directly affect the tubular handling of 
urea [8]. 
Methods 
Subjects 
The study was performed in 14 subjects with persistent 
azotemia (11 men and 3 women) and normal serum creatinine 
level and in lO control subjects (10 men), matched for age with 
azotemie subjects. The age of azotemic subjects, ranging from 
29 to 5] years with a mean value of 37.5, was similar to the age 
of the control subjects (mean: 36.9: range, 26 to 50 years). 
Persistent azotemia was defined as values of plasma urea 
concentration greater than or equal to 60 (10 mmollliter) 
for at least one year. All subjects received a controlled diet with 
constant intake of protein (1 g/kg of wt), sodium (100 
mmol per day), phosphorus (35 mmol per and calories (30 
kCallkg of body wt) throughout the study. The subjects were 
taking no medications for at least one month before the study; 
none of the azotemic subjects were aspirin or other 
nonsteroidal anti-inflammatory agents; the use of alcohol, to-
bacco, tea, and coffee was prohibited. A of stabilization 
was allowed until body weight and plasma urea concentration 
were constant, and the magnitude of changes in urinary sodium 
and phosphorus did not exceed 10% in three consecutive days. 
In each subject with azotemia, medical physical exam-
ination, radiographic and laboratory for signs of 
renal disease were performed. The subjects gave their informed 
consent to participate in the study. 
Study design 
Clearance studies and hormonal determinations were per-
the lnternational of Nephrology formed in all subjects during basal antidiuresis and 
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water diuresis. These three different conditions were random-
ized and separated at least a one week interval. 
Basal period. morning for three days, body weight was 
registered at 8:30 a.m. and blood was obtained at 9 a.m. for 
determination of plasma urea, creatinine, sodium, potassium 
and osmolality. The mean concentration in two consecutive 
samples was taken as the average plasma concentration in the 
corresponding 24-hour interval. Urinary excretion of urea, 
creatinine, sodium, potassium, and osmolality were measured 
by 24-hour urine collections. Daily urea nitrogen appearance 
(UNA) was calculated according to Walser et al [9] as: 
UNA = (PUN f - X BW j x 0.60 + (BWf BWD X 
PUNt' + UNe 
where j and f indicate initial and final values for the period of 
measurements, respectively; PUN is plasma urea nitrogen; BW 
is body weight; 0.60 is the fraction of BW representing urea 
compartment and is urea nitrogen excretion. 
In the same three of the basal period, plasma renin 
activity (PRA) and plasma antidiuretic hormone (ADH) were 
measured on samples obtained at 9 a.m. after two hours of 
standing position. GFR and renal plasma flow were estimated 
by inulin and para-aminohippurate clearances in the morning, 
with the subjects in the recumbent position; a constant infusion 
containing inulin and para-aminohippuni.te (PAH) (0. 
was given intravenously. After an equilibration period of at 
least 45 minutes, urine was collected by spontaneous voiding at 
intervals of 60 to 80 minutes, and blood was sampled at the 
beginning and the end of the collection period. The mean of at 
least three consecutive clearance periods was used as a mea-
sure of GFR and renal plasma flow. 
For the evalation of urinary excretion of PGE2 and 6-keto-
PGF]a, sexual was avoided for at least two to three 
days prior to urine collection in order to avoid potential 
interference of prostatic with urinary PGs . Urinary excretion of 
PGE2 and 6-keto-PGF1a were measured on the same days of 
urea clearance determinations; urine was refrigerated immedi-
ately after collection and samples were stored at - 20°C until the 
assay. Plasma volume was determined by Evan's blud dilution. 
Screening of plasma urea and creatinine was also performed in 
consanguineous relatives of azotemic subjects. 
Additional study. In eight of the ten normal subjects under 
study the effect of on fractional clearance of urea were 
also evaluated. Three basal clearance peri04s of one hour each 
were followed by the oral administration of 500 mg of aspirin 
and by three additional clearance periods of one hour. Blood 
Was sampled at the beginning and the end of each urine 
collection. Creatinine, urea, sodium, potassium concentration 
and osmolality were measured in blood and urine and the 
clearances calculated. 
Maximal antidiuresis. Food and fluid were witheld 12 hours 
before the study. Experiments began at the same hour (9 a.m.) 
one hour after the administration of l-desamino-8-D-arginine 
vasopressin (30 {-Lg intranasal route). Urine was collected 
each hour until urine osmolality reached a maximum and 
plateaued. Blood was sampled at the beginning and the end of 
each urine collection. Creatinine, urea, sodium, potassium 
concentration, and osmolality were measured in blood and 
urine, and the clearances were calculated. 
Maxima/water diuresis. All were deprived of food 
but not of water for 12 hours before the stltdy. Maximal water 
diuresis was induced by an oral load (30 mllkg of body wt in 30 
min) at 7 a. m. The subjects voided at the end of 
each 20 minute intervaL and matched urinary output plus 
insensible fluid losses of I mt/min with tap water by mouth for 
seven hours. Urine was collected each 20 minutes and the same 
clearance measurements as in maximal antidiuresis were per-
formed. 
Analytical 
Inulin was determined by method (l 0), P AH 
by method of Smith et al [Ill, creatinine by a creatinine 
autoanalyzer (Beckman Instruments, Inc., Fullerton, Califor-
nia, USA), urea by the urease method (Beckman BUN Ana-
lyzer), sodium and potassium by a flame photometer (Beck-
man), and osmolality by an osmometer (Model 250 D, Fiske 
Associates, Inc .. Uxbridge, Massachusetts). 
PRA was measured by of angiotensin I 
(Sorin Biomedica kit). Plasma ADH concentration was mea-
sured by radioimmunoassay (Medical System kit), as previ-
ously described [121. Urinary excretion of PG E2 and 6-keto-
PGF 1a (the stable hydrolysis of prostacyclin) was 
measured by radioimmunoassay 
ods previously reported [13]. 
Statistical analysis 
according to meth-
All the clearance data have been corrected for a body surface 
area of 1.73 m2 . The results were evaluated by means of a 
parametric analysis of variance. for comparisons, and 
Student's {-test for single comparisons. All values are reported 
as means ± J SE. P values under (l.05 were considered signifi-
cant. 
Results 
The 14 azotemic subjects without renal failure were recruited 
in a time interval of five years (from January 1980 to January 
1985) in our Department of Nephrology. No ethnic subgroup 
could be detected among these all coming from 
different geographic areas of our country. 
In the last day of stabilization sodium averaged 90.4 
± 0.8 SE mmol/day and 89.9 ± 0.9 SE respectively in 
control and azotemic subjects, that both groups were 
in similar condition of salt balance. No difference was found in 
mean arterial pressure (calculated as sum of diastolic pressure 
and 1/3 of differential pressure) between control and azotemic 
subjects. All subjects had blood pressure never greater than 
140/90 mm Hg, protein excretion less 150 mg/day, and no 
abnormality of urine sediment. 
Basal 
As summarized in Table I, the mean plasma urea concentra-
tion was 61.5 ± 0.7 mg per deciliter (12.5 mmoliliter) (range, 60 
to 70) in azotemic subjects. The mean: value of 24-hour urea 
clearance in the azotemic group (23.3 ± 2. mllmin, range 9.0 to 
35.2 ml/min per j.73 m2) was lower than in control 
group (49.6 ± 2.6, range 40.0 to 63.6 mllmin per 1.73 me), 
despite a normal GFR (always greater than 90 ml/min per J.73 
m2) measured as creatinine and inulin clearance. No difference 
was observed in PAH clearance, urine output, UNA, fractional 
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Table I. Basal values of control (C) and awtemic (A) groups under study (mean ± SE) 
~-. ~--"-.-.--~----- -----------_.-
Uur Curl UOsm Cosml PRA Plasma 
Urinary 6-keto-
c'n C PAH eer VICe, Pur X V UNA Cer J110sml CCr FEna BV nglmll ADH PGE2 PGF I « --_._---------;;;:;;1-;;,;jJ~7 31112- 0( fl7R% 111gl1nin % kg IhO % mllkg hr pglml nglhr 
- ----- --- -----------~-- _. ------------
C 
N = 10 110.2 570.5 L21.1 0.73 33.2 16.4 7.6 47.S 790.7 1.90 0.68 8S.2 3.8 2.6 8.0 3.9 
±3.9 ±14.9 ±4.1 ±0.05 :"::1.4 ±0.9 ±0.4 ±3.6 ±74.3 ±0.13 ±0.01 ±2.7 ±0.4 ±0.3 ±0.8 ±0.2 
A 
N 14 109.0 579.9 120 .. ' 074 61.5 14.6 6.8 21.3 79S.1 1.91 0.69 8S.0 3.4 3.2 3.8 
:+:4.1 ±II ±4.4 :1:0.07 ±O.7 ±1.3 ±0.6 ±2.3 ±63.9 ±0.16 ±O.O! ±2.2 ±O.3 ±().3 ±O.2 ±O.I 
p NS NS NS NS <0.001 NS NS <0.001 NS NS NS NS NS NS <0.001 NS 
-------- -----
Abbreviations: Crn. inulin clearance: C PAH . para-aminohippurate clearance; CCI> creatinine clearance; V, urine output; Pur, plasma urea; UUI> 
urine urea;. UNA, urea nitrogen appearance; CUI> urea clearance; UOsm , urinary osmolality; COsm , osmolar clearance; FEna , fractional sodium 
excretion; BV, blood volume; PRA, plasma renin activity; ADH; antidiuretic hormone; PGE2 , protaglandin'E2 , 6-ketoPGF ln • 6-keto-prostaglandin 
Fla: NS. not significant. To convert plasma urea values to millimoles per liter, multiply by 0.1667; to convert urinary urea excretion and urea 
nitrogen appearance values to millimoles per min .. multiply by 0.0167 
Table 2. Basal values of control subjects before (B) and after (A) inhibition of prostaglandin synthesis (mean ± SE) 
-------_._------------
Cer VICe, Pur Uur X V Cu/Cer UOs m COs mlCc, FENa 
mllminl1.73m2 % mg% mglmin % mOsmlkg % % 
.- -----------
---------- ----
123.7 0.57 30.0 18.3 SI.9 801 .91 0.71 
±8.8 ±0.05 ±3.5 ±1.3 ±8.3 ±54 ±0.15 ±0.02 
123.4 0.43 31.9 ]0.9 27.9 860 1.65 0.69 
±9.9 ±0.06 ±3.6 ± 1.4 ±5.2 ±49 ±0.14 ±0.02 
NS NS NS 0.01 0.01 NS NS NS 
Abbreviations are the same as in Tahle I. To convert plasma urea values to millimoles per liter, m1Iltiply by 0.1667: to convert urinary urea 
excretion values to millimoies per min. multiply by 0.01667 
excretion of IS odium , ratio, blood volume, PRA, and 
plasma ADH between control and azotemic subjects. The 
urinary excretion of PGE2 in the azotemic group was 3.2 ± 0.2 
ng/hr (range 1.2 tb 4.5) which was significantly lower than the 
value (8.0 2:: 0.8 ng/hr: range 4.0 to 12.1) in the control group. In 
contrast, urinary excretion of 6-keto-PGF la was not different 
between control and azotemic subjects. As showed in Figure I, 
a significant direct relationship hetween urinary excretion of 
PGE2 and fractional urea clearance (Cu/Cer) was observed in 
azotemic subjects (I' = 0.857. P < 0.001), In control subjects no 
correlation was found hetween urinary excretion of PGE2 and 
fractional urea clearance. 
A screening of plasma levels urea and creatinine was con-
ducted in 251 of 349 blood relatives. Only one subject, a brother 
of one azotemic subject, showed a value of plasma urea 
concentration greater than 60 mg/dl (l0 mmcillliter) in spite cif 
normal function. 
As summarized in Table 2, inhibition of prostaglandin syn-
thesis by aspirin caused a significant decrease of both urinary 
urea excretion and CuriCer ratio in control subjects, while 
did not change (2204 ± 130 mg% 
after aspirin). No difference was 
rved in Cer·, UOsm, COsn/Cer and fractional 
on of sodium after inhibition of PG,. 
Maxima! wztidillrcsis 
3 shows c1eal"'ance data and maximum urine 
molalities during antidiuresis. Cu/Cer was lower in azotemic 
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Fig. 1. Correlation between urinary excretion oj prostaglandin E2 
(PGE2) andjractional urea clearance (C,,,,/CcrJ in 14 azotemic subjects 
(I' = 0.857, P < 0.001). 
than in control subjects. Urinary urea excretion was less than in 
control subjects in spite of greater urea filtered load, while 
urinary urea concentration was not significantly different be-
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Table 3. Summary of clearance data during maximum antidiuresis in control (Cl and azotemic (Al groups (mean ± SE) 
,-,~. --,-
--- ---_.----_._-- ~-----
V/Ccr Pur U llr X V 
UOsm 
Cur/Cer n10smlkg Th,o/Cos m 
. 73m2 % mg% rnghnin % H2 O x 100-1111 of Ce, 
--_._-_._----- --. -- --
C 
N = 10 
A 
N 14 
p 
Abbreviations: 
liter, multiply by O. 
121.7 0.42 34.3 12.4 32.7 100S.2 1.43 0.584 
±5.S ±0.03 ±3.0 ±O.S ±3.9 ±11.2 ±O.ll ±o.on 
10.5 0.38 69.3 8.5 11.7 1147.5 1.45 0.687 
±4.3 ±0.03 ±2.7 ±0.2 ±0.8 ±8.0 ±0.13 ±0.026 
NS NS <0.001 <0.05 <0.001 <0.001 NS <0.02 
------ -----------.----
free-water reabsorption; other abbreviations are the same as in Table 1. To convert plasma urea values to millimoles per 
, to convert urinary urea excretion values to millimoles per minute, multiply by 0.0167 
Table 4. Summary of clearance data during maximum water diuresis in control (Cl and azotemic (AI groups (mean = sEI 
-. -._-----_ .. --- ----.--- ------- ---
LU.',)l\ CU"m 
CCr V/Ccr Pur Uur x V Cu/Ce ! mOsmlkg 
mllminl1.73m2 % mg% mglmin % fhO mllminll.73m" 
-----_.--------- --- -- - _._-------------
C 
N = 10 117.7 14.9 25.1 17.5 59.2 59.1 3.6 
±9.1 ± 1.1 ±2.1 ±2.8 ±6.4 ±5. ±0.2 
A 
N = 14 125.8 13.3 43.1 20.7 35.3 62.0 3.9 
±4.0 ±O.S ± 1.9 ±3.3 ±3.7 ±6.6 ±0.6 
p NS NS <0.001 NS <0.001 NS NS 
Abbreviations: 
liter, multiply by O. 
free-water generation; other abbreviations are the same as in Table I. To convert plasma urea values to millimoles per 
to convert urinary urea excretion values to millimoles per minute, mUltiply by 0.0167 
tween normal and azotemic subjects (2474 ± 154 and 2131 ± 
162 mg%, respeCtively). Maximum urine osmolality was slightly 
but significantly greater than control subjects; UOsm ranged 
between 1101 and 197 mOsm/kg or H 20 in azotemic subjects 
and between 958 and 1058 mOsm/kg of H 20 in control subjects. 
Free-water reabsorption relative to osmolar clearance per unit 
of GFR, calculated as creatinine clearance, was significantly 
greater in azotemic than in control subjects. 
Maximal water diuresis 
The data are shown in Table 4. The sustained water diuresis 
lead to a similar minimum value in urine osmolality (range 22 to 
81 mOsm/kg of and to a similar maximum value in urine 
output (range 12.8 to 24.0 mllmin:r in' control and azotemic 
subjects. Seven hours of water diuresis lead to a significant fall 
in plasma urea concentration in both control and azotemic 
subjects, from an initial value of 32.7 ± 2.9 mg% (5.4 ± 0.5 
mmol/liter) to 25. ± 2.1 mg% (4.2 ± 0.3 mmollliter) (P < 0.025) 
in control subjects and from an initial value of 58.5 ± 0.8 mg% 
(9.7 ± 0.1 mmol/liter) to 43.1 ± 1.9 (7.2 ± 0.3 mmol/liter) (P < 
0.001) in azotemic subjects. As shown in Table 4, after seven 
hours of water diuresis, the plasma urea concentration reo 
mained greater while CurJCCr ratio was lower in azotemic than 
in control subjects. CH,o was within the normal range. 
It is important to note that both the increase in urea excretion 
and the fall in plasma urea concentration from antidiuresis to 
water diuresis was significantly greater in azotemic than 
in control subjects (12.3 ± 2.6 mg/min vs. 5.2 ± 1.5 mg/min, P 
< 0.05 and 18.6 ± 2.2 vs. 7.1 
tively). 
Discussion 
mg%, P < 0.01, respec-
Plasma urea concentration is the result of the balance be· 
tween urea formation and its renal excretion. In our azotemic 
subjects, extrarenal causes of azotemia (that is, increased urea 
loads from diets and/or tissue metabolism) could be excluded 
since azotemia remained unchanged despite normal alimentary 
protein intake and normal urea appearance. A dispro-
portionate decrease in urea clearance compared with GFR is a 
well known effect of salt [5]. A decrease in "effec-
tive" intravascular volume is known to be associated with a 
reduced clearance of sodium and urea [14]. This condition 
known as "prerenal azotemia" was excluded in our azotemi€ 
subjects, since blood volume, renal plasma flow and fractional 
excretion of sodium were normal. The decreased urea clearance 
might have been accounted for by a reduced intake of water. 
But urine flow rate, urine/plasma osmolality ratio and plasma 
concentration of ADH were normal in basal conditions, ruling 
out such a possibility. 
The results of our study indicate that persistent azotemia 
despite a normal renal function is due to a decreased renal 
clearance of urea, as reported in subjects with familial azotem' 
[7]. In familial azotemia the defect in renal urea clearance is 
inherited as an autosomal dominant trait. In our azotemic 
subjects this type of genetic inheritance was ruled out 
studies performed in their relatives. Despite that, a gen 
defect, albeit sporadic, cannot be excluded. 
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Micropuncture studies have demonstrated that urea is filtered 
by the glomeruli, reabsorbed and secreted by the tubules of 
mammalian kidneys r 15J. Thus a defect in any of these pro-
cesses might impair urea excretion. 
Normally the molecule of urea is not bound to plasmatic 
protein so that urea is filtered by the glomerulus [16]. 
Theoretically. should a urea-binding protein be produced by 
the azotemic subjects. filtration of urea would be reduced 
thereby impairing urea excretion. However, it has been dem-
onstrated by Hsu et al [7J that the separation of proteins by in 
vitro dialysis on the samples of azotemic subjects did not 
change the plasma concentration of urea. Therefore. increased 
protein binding of urea leading to decreased filtration and 
excretion seems unlikely. 
The mechanism of decreased urea excretion in azotemic 
subjects is due to an alteration in the tubular handling of urea. 
During basal period. in fact, urea clearance compared with GFR 
was markedly reduced and. in maximal antidiuresis, it is 
particularly impressive that the urinary excretion of urea was 
less than in control subjects in spite of the greater urea filtered 
load. The latter finding may account for the observed increase 
both in maximum urine osmolality and in fractional free-water 
reabsorption relative to osmolar delivery (T¥!'o/Cos m ) through 
the generation of high medullary solute co'ncentration (the 
driving force for distal water reabsorption). since urea is the 
principal inner medullary solute. 
For comparing the renal handling of urea in azotemic and 
control subjects during water diuresis, we have used the clear-
ances of seventh hour in order to avoid the transient increment 
of urea excretion. called urea exaltation [17], following the 
initial period of rapid hydration. After seven hours of water 
diuresis, the renal diluting ability, evaluated as minimum urine 
osmolality and generation of free-water, was similar to those of 
normal controls and the plasma urea concentration exhibited a 
significant drop to near normal levels. Conceivably, with more 
chronic hydration azotemic subjects would lower their plasma 
urea concentration to normal. Thus, in these subjects the 
azotemic condition may be masked during period of high fluid 
intake and might be more detected clinically during 
of water deprivation. The state of hydration is therefore 
to determine appropriate changes in the fractional 
Reduction in fractional urea clearance has also been demon-
strated by studying the physiologic effects of reducing protein 
on urea excretion in man and other species r IS, 19]. In 
s on a low protein diet. the fraction of filtered urea present in 
early distal convolutions is significantly greater than in rats 
normal protein diet ; furthermore, more urea is reab-
from collecting duct in the former than in the latter [20]. 
is interesting to observe that the state of dehydration deter-
a marked increase in plasma urea concentration in rats on 
w protein; the fraction of excreted filtered urea decreases 
y with decreasing urine flow rate in low protein but 
in normal protein animals [21]. These observations in rats 
compatible with our results in azotemic subjects. The 
of reducing protein intake on urea excretion, however, 
y an impaired ability of the kidney to concentrate urine; 
concentration and osmolality. in fact. were reduced at the 
illary tip in low protein rats [2 J]. On the contrary, our 
azotemic subjects exhibited an improved to concentrate 
urine, as mirrored by their maximum urine osmolality. 
The significant decrease in urinary excretion of POE2 in 
azotemic subjects and the significant direct correlation of uri-
nary level of PGE2 with the values of fractional urea clearance 
seem to suggest a role of these compounds in the pathogenesis 
of azotemia. Urinary PGs is a valid marker for intrarenal 
biosynthesis of PGs [22]. Recent observations [S] indicate that 
renal POs may alter the tubular handling of urea. It has been 
demonstrated by microinjection studies, in fact, that the phar-
macologic inhibition of prostaglandins and PGF2a) syn-
thesis in rats induces a significant increase of urine osmolality 
and urea reabsorption in the collecting duct, completely reo 
versed by POE2 and PGF2a addition into distal convoluted 
tubule. 
Concerning the finding 'of a significant correlation between 
POE2 excretion and fractional urea clearance in azotemic but 
not in control subjects, POE2 might operate by a critical 
thereshold level rather than by a dose-response curve. A small 
overlap in the range of PGE2 between the two groups (azotemic 
1.2 to 4.5, control 4 to 12.1 ng/hr) is present: the value of one 
control subject (4.0 ng/hr), in fact, falls below the values of 
three azotemic subjects (4.5, 4.4 and 4.2 But, while the 
latter are near to highest PGE2 values of azotemic subjects (3.9, 
3.S, 3.6, 3.4, etc., ng/hr), the value of the control subject clearly 
falls below the lowest PGE2 values of control subjects (5.1.6.9, 
6.9, 7.1, etc., ng/hr). Thus, if we take out this isolated value, our 
data appear to be compatible with the mentioned hypothesis of 
a critical thereshold level for the proposed role of renal POE2. 
Further evidence that PGE2 appear to inhibit reabsorption of 
urea was suggested by the acute effects of the administration of 
cyclooxygenase inhibitors in normal subjects (Table 2). rnhibi-
tion of POE2 synthesis, in fact, performed according to a 
protocol already experienced in our laboratory [23], signifi· 
cantly reduced fractional clearance of urea in normal subjects 
(Table 2) to approximately the same value attained in azotemic 
subjects (Table 1). The rate of PGE2 synthesis varies directly 
with urine flow, so that it can be increased maximal 'water 
diuresis [24]. The increase in urea excretion and the fall in 
plasma urea concentration observed in azotemic subjects when 
going from antidiuresis to water diuresis were significantly 
greater than in normal subjects. These findings suggest that the 
increase of prostaglandin synthesis, induced water load, may 
correct urea retention in azotemic subjects increasing urea 
excretion. 
The reduced renal biosynthesis of PGE:., might affect urea 
reabsorption by two mechanisms. (1) A reduction in PGs might 
decrease the inner medullary blood-flow [25] and lead to an 
enhanced, inner medullary osmotic gradient, thereby increasing 
the rate of water reabsorption and the transtubular concentra-
tion gradient for urea. The finding of unchanged CPAH in 
azotemic subjects does not rule out the of a signifi· 
cant change in inner medullary blood flow since CPAH reflects 
mainly cortical plasma flow and not flow [26]. (2) 
Animal studies have given evidence that may directly lower 
the urea permeability of the collecting duct [S]. Passive reab-
sorption of urea may therefore be enhanced because of a 
reduced inhibitory action of PO s on the wall permeability to 
urea in the medullary collecting duct [S]. 
There is no evident explanation for the lower urinary excre-
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tion of PGE2 in azotemic group. It is known that urinary 
excretion of PGs varies directly with urine flow rate [27] and 
that patients with chronic glomerular disease may have a 
reduced excretion of [28]. The mean urinary volume of 
azotemic subjects, however, was not different from control 
subjects and no abnormality of the urine analysis was present. 
Experimental studies in animals have suggested that the 
excessive urea reabsorption is improbable in the distal convo-
luted tubule and in the cortical collecting duct, since these 
tubular sites are almost impermeable to urea regardless of 
whether or not ADH is present [29]. Furthermore, if increased 
reabsorption of urea in the distal convoluted tubule and cortical 
collecting duct has been responsible for decreased urea clear-
ance, the urinary concentrating ability would be expected to be 
impaired by decreasing medullary solute concentration, an 
effect in contrast with our data. 
Urea handling by the medullary collecting duct has been 
studied by micropuncture and/or tubular perfusion [30-34]. 
These studies suggest that the permeability of the papillary 
collecting duct to urea is much greater than that of the outer 
medullary collecting duct. Thus, in the present study it is likely 
that urea transport in the distal segments of the nephron 
primarily involves reabsorption from the papillary collecting 
duct, with recycling of urea in to the loop of Henle and the vasa 
recta. 
Taken together, the results of our study 90 not allow an 
ignoring of abnormal proximal urea reabsorption in the 
azotemic subjects, but suggest that azotemia is mainly due to 
increased tubular reabsorption in the distal part of nephron. An 
enhanced recycling of urea in the medulla may account for the 
high urinary solute concentration and free-water reabsorption. 
The reduced renal biosynthesis of PGE2 may participate in the 
pathogenesis of azotemia quite indirectly, through a reduced 
counteracting action on renal effect of ADH. The consequent 
increase in urine concentration will provide a greater urea 
concentration gradient between tubular fluid and interstitium, 
thereby enhancing urea back diffusion. Neither the precise 
mechanism causing increased urea reabsorption, nor the exact 
tubular site where this occurs are apparent from the present 
study. 
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